HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fei Ding Selected Research

PQQ Cofactor (Pyrroloquinoline Quinone)

5/2021Pyrroloquinoline quinone promotes mitochondrial biogenesis in rotenone-induced Parkinson's disease model via AMPK activation.
9/2020Pyrroloquinoline Quinone Inhibits Rotenone-Induced Microglia Inflammation by Enhancing Autophagy.
9/2019PQQ ameliorates skeletal muscle atrophy, mitophagy and fiber type transition induced by denervation via inhibition of the inflammatory signaling pathways.
11/2018Mitochondrial regulation by pyrroloquinoline quinone prevents rotenone-induced neurotoxicity in Parkinson's disease models.
1/2016Neuroprotective effects of pyrroloquinoline quinone against rotenone injury in primary cultured midbrain neurons and in a rat model of Parkinson's disease.
11/2015Pyrroloquinoline quinone-conferred neuroprotection in rotenone models of Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fei Ding Research Topics

Disease

47Neoplasms (Cancer)
01/2022 - 08/2008
17Atrophy
10/2021 - 01/2006
17Muscular Atrophy (Muscle Atrophy)
04/2021 - 01/2006
13Inflammation (Inflammations)
12/2020 - 01/2009
11Ischemic Stroke
10/2019 - 02/2011
10Ischemia
09/2021 - 02/2010
9Peripheral Nerve Injuries
11/2019 - 01/2012
8Neurodegenerative Diseases (Neurodegenerative Disease)
07/2017 - 12/2008
7Parkinson Disease (Parkinson's Disease)
05/2021 - 06/2009
7Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2019 - 02/2010
6Body Weight (Weight, Body)
04/2022 - 09/2007
6Melanoma (Melanoma, Malignant)
11/2021 - 01/2017
6Crush Injuries
11/2019 - 05/2007
6Spinal Cord Injuries (Spinal Cord Injury)
06/2016 - 05/2007
5Mitochondrial Diseases (Mitochondrial Disease)
05/2021 - 02/2010
5Brain Ischemia (Cerebral Ischemia)
11/2018 - 01/2014
4Hypoxia (Hypoxemia)
01/2022 - 08/2011
4Alzheimer Disease (Alzheimer's Disease)
01/2021 - 04/2011
4Infarction (Infarctions)
01/2019 - 01/2016
4Brain Injuries (Brain Injury)
11/2017 - 12/2013
3Colonic Neoplasms (Colon Cancer)
06/2021 - 10/2015
3Neuroblastoma
05/2021 - 01/2017
3Neoplasm Metastasis (Metastasis)
01/2020 - 07/2018
3Pancreatic Neoplasms (Pancreatic Cancer)
09/2019 - 08/2015
3Paralysis (Palsy)
11/2018 - 07/2015
2Triple Negative Breast Neoplasms
01/2022 - 05/2020
2Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2022 - 01/2020
2Acute Kidney Injury (Acute Renal Failure)
01/2022 - 01/2021
2Breast Neoplasms (Breast Cancer)
11/2021 - 01/2019
2Neutropenia
10/2021 - 12/2019
2Adenocarcinoma
06/2021 - 12/2020
2Stomach Neoplasms (Stomach Cancer)
06/2021 - 01/2020
2Infections
05/2021 - 08/2014
2Virus Diseases (Viral Diseases)
03/2021 - 01/2020
2Glioblastoma (Glioblastoma Multiforme)
03/2021 - 01/2019
2Carcinoma (Carcinomatosis)
12/2020 - 08/2008
2Carcinogenesis
01/2019 - 01/2019

Drug/Important Bio-Agent (IBA)

18Proteins (Proteins, Gene)FDA Link
11/2021 - 01/2006
17MicroRNAs (MicroRNA)IBA
03/2021 - 04/2012
17Neuroprotective AgentsIBA
09/2020 - 12/2008
15Glucose (Dextrose)FDA LinkGeneric
01/2021 - 12/2013
11Peptides (Polypeptides)IBA
11/2021 - 01/2010
9Pharmaceutical PreparationsIBA
11/2021 - 06/2009
8Oxygen (Dioxygen)IBA
01/2021 - 12/2013
62- (4- methoxyphenyl)ethyl- 2- acetamido- 2- deoxyglucopyranosideIBA
09/2021 - 01/2014
6Biomarkers (Surrogate Marker)IBA
06/2021 - 12/2016
6RotenoneIBA
05/2021 - 11/2015
6PQQ Cofactor (Pyrroloquinoline Quinone)IBA
05/2021 - 11/2015
6DNA (Deoxyribonucleic Acid)IBA
01/2021 - 01/2019
6Messenger RNA (mRNA)IBA
01/2019 - 01/2006
6Caspase 3 (Caspase-3)IBA
02/2018 - 02/2010
5Nucleic AcidsIBA
03/2021 - 12/2018
5Small Interfering RNA (siRNA)IBA
12/2020 - 10/2015
5TNF Receptor-Associated Factor 6 (TRAF6)IBA
09/2019 - 06/2014
5Biological ProductsIBA
04/2019 - 05/2012
5Reactive Oxygen Species (Oxygen Radicals)IBA
01/2018 - 12/2008
5rhodiolosideIBA
06/2014 - 12/2008
4Insulin (Novolin)FDA Link
04/2021 - 09/2007
4CytokinesIBA
03/2021 - 01/2012
4Interleukin-6 (Interleukin 6)IBA
12/2020 - 06/2012
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2020 - 01/2009
4isoquercitrinIBA
01/2020 - 12/2013
3LipidsIBA
04/2022 - 01/2019
3Therapeutic UsesIBA
01/2022 - 01/2018
3veliparibIBA
01/2022 - 09/2017
3AntigensIBA
11/2021 - 01/2017
3Proteasome Endopeptidase Complex (Proteasome)IBA
04/2021 - 09/2019
3UbiquitinIBA
04/2021 - 09/2019
3GemcitabineFDA Link
09/2019 - 09/2017
3AntioxidantsIBA
01/2018 - 04/2015
3MyostatinIBA
05/2007 - 01/2006
2A-Form DNA (A-DNA)IBA
01/2022 - 01/2021
2ProdrugsIBA
01/2022 - 11/2021
2PlatinumIBA
01/2022 - 05/2016
2Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2022 - 12/2019
2VaccinesIBA
11/2021 - 01/2019
2EnzymesIBA
11/2021 - 05/2012
2InterferonsIBA
11/2021 - 01/2019
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
07/2021 - 02/2010
2RNA-Binding Proteins (RNA-Binding Protein)IBA
06/2021 - 04/2021
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
06/2021 - 12/2020
2Organoselenium CompoundsIBA
06/2021 - 12/2020
2polyethylene glycol polyethyleneimine nanogelIBA
03/2021 - 12/2020
2Beclin-1IBA
12/2020 - 11/2019
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
09/2020 - 09/2014
2Myosin Heavy Chains (Myosin Heavy Chain)IBA
01/2020 - 01/2018
2IpilimumabIBA
01/2020 - 01/2017
2ChitosanIBA
01/2020 - 01/2012
2Lipoproteins (Lipoprotein)IBA
04/2019 - 01/2019
2CateninsIBA
01/2019 - 01/2017
2Long Noncoding RNAIBA
01/2019 - 07/2015
2Dexamethasone (Maxidex)FDA LinkGeneric
11/2018 - 06/2014

Therapy/Procedure

20Therapeutics
01/2022 - 10/2011
16Denervation
10/2021 - 01/2006
10Drug Therapy (Chemotherapy)
05/2020 - 01/2015
3Noninvasive Ventilation
01/2022 - 01/2020
3Immunotherapy
03/2021 - 01/2019
2Radiotherapy
01/2022 - 01/2017
2Intraperitoneal Injections
10/2019 - 12/2009
2Intravenous Injections
04/2019 - 01/2009